Norges Bank Relay Therapeutics, Inc. Transaction History

Norges Bank

$655 Billion
Q2 2024

A detailed history of Norges Bank transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Norges Bank holds 3,319,342 shares of RLAY stock, worth $19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,319,342

Holding current value

$19 Million

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $19.6 Million - $26.6 Million	3,319,342 New	3,319,342 $21.6 Million
Q4 2023 Feb 09, 2024	BUY	$6.01 - $11.48 $18.4 Million - $35.2 Million	3,068,973 New	3,068,973 $33.8 Million
Q3 2023 Nov 13, 2023	SELL	$8.24 - $12.97 $14.3 Million - $22.4 Million	-1,730,687 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$9.99 - $18.27 $17 Million - $31.2 Million	-1,705,558 Reduced 51.38%	1,613,784 $20.3 Million
Q2 2023 Aug 14, 2023	SELL	$9.99 - $18.27 $14.2 Million - $25.9 Million	-1,417,188 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$15.0 - $22.76 $24.2 Million - $36.7 Million	1,613,784 New	1,613,784 $26.6 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $25.3 Million - $43 Million	1,788,323 New	1,788,323 $26.7 Million
Q3 2022 Nov 13, 2023	BUY	$18.07 - $31.37 $31.3 Million - $54.3 Million	1,730,687 New	1,730,687 $38.7 Million
Q2 2022 Aug 14, 2023	BUY	$13.31 - $34.88 $18.9 Million - $49.4 Million	1,417,188 New	1,417,188 $23.7 Million
Q1 2022 May 12, 2023	SELL	$20.26 - $32.36 $17.2 Million - $27.5 Million	-850,397 Reduced 47.55%	937,926 $28.1 Million
Q1 2022 May 09, 2022	SELL	$20.26 - $32.36 $16.6 Million - $26.5 Million	-820,000 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$26.0 - $37.03 $21.3 Million - $30.4 Million	820,000 New	820,000 $25.2 Million
Q3 2021 Nov 14, 2022	BUY	$29.75 - $37.99 $14.8 Million - $18.9 Million	497,765 New	497,765 $15.7 Million
Q3 2021 Nov 05, 2021	SELL	$29.75 - $37.99 $6.86 Million - $8.76 Million	-230,630 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$27.5 - $38.19 $6.34 Million - $8.81 Million	230,630 New	230,630 $8.44 Million
Q2 2021 Aug 10, 2021	SELL	$27.5 - $38.19 $5.68 Million - $7.88 Million	-206,396 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$32.52 - $61.53 $6.71 Million - $12.7 Million	206,396 New	206,396 $7.14 Million
Q1 2021 May 07, 2021	SELL	$32.52 - $61.53 $6.8 Million - $12.9 Million	-209,085 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$35.51 - $54.03 $7.42 Million - $11.3 Million	209,085 New	209,085 $8.69 Million

Others Institutions Holding RLAY

# of Institutions

180

Shares Held

127M

Call Options Held

1.7K

Put Options Held

18K

Sb Investment Advisers (Uk) LTD London, X0

27.9M
Shares

$159 Million
1.68% of portfolio
Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$66.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.5M
Shares

$60.2 Million
0.0% of portfolio
Casdin Capital, LLC New York, NY

8.45M
Shares

$48.2 Million
4.75% of portfolio
Bellevue Group Ag Kuesnacht, V8

6.38M
Shares

$36.4 Million
0.7% of portfolio

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $686M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account